The health ministry of Panama has said it would allow emergency use of the Pfizer Inc (NYSE:PFE)-BioNTech (Nasdaq:BNTX) COVID-19 vaccine for children aged 12 years and older, Reuters news agency reported on Tuesday.
However, no details were given on when it would start.
The health ministry stated that authorisation of the vaccine for children from 12 to 16 was based on data showing it was effective for that age group as well as for adults.
The Pfizer-BioNTech vaccine is already authorised for those older than 16 in Panama.
Immuno Cure and PharmaJet collaborate for novel HIV therapeutic DNA vaccine advancement
Bavarian Nordic sells US Priority Review Voucher for USD160m
Bavarian Nordic sells US Priority Review Voucher for USD160m
ArcticZymes Technologies launches GMP-grade nuclease for viral vector manufacturing
Merck launches Phase 3 trial for dengue vaccine candidate V181
BioNet and Bio Farma sign MoU on TdaP vaccine
Dx&Vx accelerates universal COVID-19 vaccine development
Moderna withdraws application for flu-COVID combination vaccine pending additional efficacy data
CTP delivers 18,000 sqm Serbian facility for SCHOTT Pharma to support global expansion
LakeShore Biopharma launches novel packaging solution for YSJA rabies vaccine (Vero cell)
Scancell partners with NHS Cancer Vaccine Launch Pad to accelerate melanoma trial recruitment
Orexo reports positive results for powder-based intranasal vaccine using AmorphOX technology
GC Biopharma's BARYTHRAX receives Korean regulatory approval